“We’ve seen great momentum over the last year with customers and collaborators using our SMRT Sequencing technology for human genetic research and believe we are in a better position than ever to showcase our products going into this important annual meeting,” said
Attendees at the meeting can learn more about SMRT Sequencing at the following presentations:
Podium Presentations:
-
Discovery and Impact of Balanced Inversion Polymorphisms
Jan Korbel, European Molecular Biology Laboratory (EMBL)
-
Completion of the 1000
Genomes Project : Results, Lessons Learned and Open QuestionsGoncalo R. Abecasis ,University of Michigan School of Public Health
-
High-throughput Determination of Long INterspersed Element-1 Integration Preferences in the Human Genome
Diane A. Flasch ,University of Michigan Medical School
-
Increased Complexity of the Human Genome Revealed by Single-Molecule Sequencing
Mark Chaisson , University ofWashington
Workshop
Pacific Biosciences will host a workshop: “A New Look at the Human Genome – Novel Insights with Long-Read PacBio Sequencing,” on
-
Increased Complexity of the Human Genome Revealed by Single-Molecule Sequencing
Evan Eichler , Ph.D., University ofWashington -
Defining a Personal, Allele-Specific, and Single-Molecule Long-Read Transcriptome
Hagen Tilgner , Ph.D.,Stanford University -
Long-Read Multiplexed Amplicon Sequencing: Applications for Epigenetics and Pharmacogenetics
Stuart Scott , Ph.D.,Icahn School of Medicine at Mount Sinai
Attendees can also visit members of the PacBio staff at booth #931, and view numerous poster presentations about SMRT Sequencing on topics such as HLA genotyping, resolving ‘dark matter’ in human genomes, transcriptome sequencing and DNA methylation analysis, in the Exhibit Hall.
A number of recent publications and presentations have highlighted the advantages of using long-read SMRT Sequencing data to extend the view of human genetic variation. The long sequence reads provided by the PacBio RS II are complementary to short reads from high-throughput machines because they enable human genome researchers to, for example, sequence complex genomic regions, resolve structural variation, phase haplotypes, improve the utility and mapping ability of reference genomes, fill gaps, and validate variant calls. This provides the most comprehensive view possible of the human genome.
For more information or to register for the PacBio workshop visit: https://programs.pacificbiosciences.com/l/1652/2014-08-22/2wst89
About the PacBio RS II and SMRT Sequencing
Pacific Biosciences’ SMRT Sequencing technology achieves the industry’s longest read lengths, highest consensus accuracy, and the least degree of bias. These characteristics, combined with the ability to detect many types of DNA base modifications (e.g., methylation) as part of the sequencing process, make the PacBio RS II an essential tool for many scientists studying genetic and genomic variation. The PacBio platform provides a sequencing solution that can address a growing number of complex medical, agricultural, and industrial problems.
About Pacific Biosciences
Forward Looking Statements
All statements in this press release that are not historical are forward-looking statements, including, among other things, future uses of the Company’s products, the Company’s prospects and other future events. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are, in some cases, beyond the Company’s control and could materially affect actual results. Factors that could materially affect actual results can be found in our filings with the
CONTACT: For Pacific Biosciences: Media:Nicole Litchfield 415.793.6468 nicole@bioscribe.com Investors:Trevin Rard 650.521.8450 ir@pacificbiosciences.com
Source:
News Provided by Acquire Media